Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback

Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report

In the period from November 2, 2026 to November 6, 2026 (each inclusive), 205,197 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
3 November 2026	7,363	38.4101	282,813.57	CEUX
3 November 2026	196,634	38.7212	7,613,904.44	XETR
4 November 2026	1,000	39.9333	39,933.30	XETR
5 November 2026	100	41.8532	4,185.32	XETR
6 November 2026	100	41.8919	4,189.19	XETR

A Total Fina Elf of 11,252,037 shares has been acquired within the framework of the first tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.